Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Nonproprietary Naming of Biological Products; Withdrawal, 40704 [2016-14722]
Download as PDF
<![CDATA[
40704
Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices
investigations per year. Each
investigation will involve on average
200 respondents. The total time burden
is 2,084 hours. There will be no cost to
the respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Type of respondents
Form name
Adult at least 18 years old using a private
well for tap water.
Screening Form ..............................................
2,500
1
6/60
Questionnaire .................................................
Urine Specimen and Tap Water Sample Collection.
2,000
2,000
1
1
35/60
20/60
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
OMB. FDA is withdrawing the proposed
collection of information that published
on June 2, 2016, at this time.
[FR Doc. 2016–14724 Filed 6–21–16; 8:45 am]
Dated: June 16, 2016.
Leslie Kux,
Associate Commissioner for Policy.
BILLING CODE 4163–18–P
[FR Doc. 2016–14722 Filed 6–21–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Health Resources and Services
Administration
[Docket No. FDA–2013–D–1543]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Guidance for
Industry on Nonproprietary Naming of
Biological Products; Withdrawal
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
This document withdraws a
Food and Drug Administration (FDA)
notice that published in the Federal
Register of June 2, 2016 (81 FR 35367).
DATES: This notice is withdrawn on June
22, 2016.
FOR FURTHER INFORMATION CONTACT:
Howard Muller, Center for Drug
Evaluation and Research (CDER), 10903
New Hampshire Ave., Bldg. 51, Rm.
6234, Silver Spring, MD 20993–0002,
301–796–3474.
SUPPLEMENTARY INFORMATION: FDA
published a notice in the Federal
Register of June 2, 2016, informing
interested parties that the proposed
collection of information entitled
‘‘Guidance for Industry on
Nonproprietary Naming of Biological
Products’’ had been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
and inviting the public to submit
comments on the proposed collection to
mstockstill on DSK3G9T082PROD with NOTICES
VerDate Sep<11>2014
20:02 Jun 21, 2016
Jkt 238001
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects (section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995), the
Health Resources and Services
Administration (HRSA) announces
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
from the public regarding the burden
estimate, below, or any other aspect of
the ICR.
DATES: Comments on this ICR should be
received no later than August 22, 2016.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N–39, 5600 Fishers
Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
SUMMARY:
Withdrawal of notice.
SUMMARY:
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
or call the HRSA Information Collection
Clearance Officer at (301) 443–1984.
When
submitting comments or requesting
information, please include the
information request collection title for
reference.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Data Collection Tool for State Offices of
Rural Health Grant Program
OMB No. 0915–0322—Extension
Abstract: The mission of the Federal
Office of Rural Health Policy (FORHP)
is to sustain and improve access to
quality care services for rural
communities. In its authorizing
language (section 711 of the Social
Security Act [42 U.S.C. 912]), Congress
charged FORHP with administering
grants, cooperative agreements, and
contracts to provide technical assistance
and other activities as necessary to
support activities related to improving
health care in rural areas. In accordance
with the Public Health Service Act,
section 338J (42 U.S.C. 254r), HRSA
proposes to continue the State Offices of
Rural Health (SORH) Grant Program—
Funding Opportunity Announcement
(FOA) and Forms for the Application.
The FOA is used by 50 states in
preparing applications for grants under
the SORH Grant Program of the Public
Health Service Act, and in preparing the
required report.
Need and Proposed Use of the
Information: FORHP seeks to continue
gathering information from grantees on
their efforts to provide technical
assistance to clients within their states.
SORH grantees submit a Technical
Assistance Report that includes: (1) The
total number of technical assistance
encounters provided directly by the
grantee, and (2) the total number of
unduplicated clients that received direct
technical assistance from the grantee.
The Technical Assistance Report is
submitted via the HRSA Electronic
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Page 40704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14722]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-D-1543]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Guidance for Industry
on Nonproprietary Naming of Biological Products; Withdrawal
AGENCY: Food and Drug Administration, HHS.
ACTION: Withdrawal of notice.
-----------------------------------------------------------------------
SUMMARY: This document withdraws a Food and Drug Administration (FDA)
notice that published in the Federal Register of June 2, 2016 (81 FR
35367).
DATES: This notice is withdrawn on June 22, 2016.
FOR FURTHER INFORMATION CONTACT: Howard Muller, Center for Drug
Evaluation and Research (CDER), 10903 New Hampshire Ave., Bldg. 51, Rm.
6234, Silver Spring, MD 20993-0002, 301-796-3474.
SUPPLEMENTARY INFORMATION: FDA published a notice in the Federal
Register of June 2, 2016, informing interested parties that the
proposed collection of information entitled ``Guidance for Industry on
Nonproprietary Naming of Biological Products'' had been submitted to
the Office of Management and Budget (OMB) for review and clearance
under the Paperwork Reduction Act of 1995 and inviting the public to
submit comments on the proposed collection to OMB. FDA is withdrawing
the proposed collection of information that published on June 2, 2016,
at this time.
Dated: June 16, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-14722 Filed 6-21-16; 8:45 am]
BILLING CODE 4164-01-P
